A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.
Paik PK; James LP; Riely GJ; Azzoli CG; Miller VA; Ng KK; Sima CS; Heelan RT; Kris MG; Moore E; Rizvi NA; Cancer Chemotherapy And Pharmacology, 2011, vol. 68, issue 5, p 1331, ISSN 14320843. ISBN 14320843.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef